TFS Capital’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

TFS Capital’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-12,954	Closed	-$515K	–	1022
2016 Q3	$515K	Sell	12,954 -29,450	-69%	-$329K	0.12%	233
2016 Q2	$533K	Buy	+42,404	New	+$395K	0.1%	358
2016 Q1	–	Sell	-40,384	Closed	-$406K	–	1204
2015 Q4	$406K	Buy	40,384 +13,929	+53%	+$145K	0.04%	460
2015 Q3	$256K	Buy	26,455 +2,770	+12%	+$38.9K	0.02%	691
2015 Q2	$409K	Buy	+23,685	New	+$346K	0.04%	600
2014 Q4	–	Sell	-1,149	Closed	-$12K	–	1292
2014 Q3	$12K	Sell	1,149 -8,759	-88%	-$173K	﹤0.01%	1021
2014 Q2	$605K	Buy	+9,908	New	+$603K	0.05%	570

TFS Capital's TBRA Position: Q4 2016 in Review

TFS Capital sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 12,954 shares — an estimated $515K sold.

TFS Capital first reported a position in TBRA in Q2 2014 and held it in 7 quarters. The position peaked at $605K in Q2 2014. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

TFS Capital reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
TFS Capital sold 12,954 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $515K.
TFS Capital first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 7 quarters.
TFS Capital's Tobira Therapeutics, Inc. Common Stock position peaked at $605K in Q2 2014.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on TFS Capital's 13F filing for Q4 2016, filed 20 Jan 2017.